Aisling O’Leary

607 total citations
31 papers, 374 citations indexed

About

Aisling O’Leary is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Aisling O’Leary has authored 31 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Aisling O’Leary's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (5 papers). Aisling O’Leary is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (5 papers). Aisling O’Leary collaborates with scholars based in Ireland, Spain and United States. Aisling O’Leary's co-authors include Colm Bergin, Matthew Lynch, Suzanne Norris, Michael Barry, Cathal Walsh, Cara Usher, Ramón San Miguel, Cillian De Gascun, Linh T. Nguyen and Michael J. Carr and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Aisling O’Leary

30 papers receiving 366 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Aisling O’Leary 138 128 96 64 60 31 374
Ivan Gardini 97 0.7× 115 0.9× 88 0.9× 12 0.2× 32 0.5× 16 253
Kim Gilchrist 67 0.5× 76 0.6× 36 0.4× 94 1.5× 15 0.3× 18 344
Lawrence Shaw 38 0.3× 29 0.2× 53 0.6× 34 0.5× 54 0.9× 18 362
Naglaa Youssef 146 1.1× 105 0.8× 17 0.2× 73 1.1× 91 1.5× 44 473
Aziz Rezapour 86 0.6× 32 0.3× 47 0.5× 40 0.6× 47 0.8× 50 341
Stephen E. Van Rompaey 283 2.1× 73 0.6× 32 0.3× 503 7.9× 69 1.1× 15 818
James Halloran 493 3.6× 415 3.2× 24 0.3× 139 2.2× 93 1.6× 19 744
Tianhua He 262 1.9× 275 2.1× 53 0.6× 56 0.9× 81 1.4× 21 562
Timothy Juday 303 2.2× 197 1.5× 59 0.6× 301 4.7× 58 1.0× 43 543
M. M. Kitahata 149 1.1× 19 0.1× 38 0.4× 245 3.8× 60 1.0× 9 478

Countries citing papers authored by Aisling O’Leary

Since Specialization
Citations

This map shows the geographic impact of Aisling O’Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisling O’Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisling O’Leary more than expected).

Fields of papers citing papers by Aisling O’Leary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisling O’Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisling O’Leary. The network helps show where Aisling O’Leary may publish in the future.

Co-authorship network of co-authors of Aisling O’Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Aisling O’Leary. A scholar is included among the top collaborators of Aisling O’Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisling O’Leary. Aisling O’Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Stephen J., et al.. (2024). Primary healthcare’s carbon footprint and sustainable strategies to mitigate its contribution: a scoping review. BMC Health Services Research. 24(1). 1630–1630. 3 indexed citations
2.
Lynch, Matthew & Aisling O’Leary. (2023). Understanding the factors influencing community pharmacist retention – A qualitative study. SHILAP Revista de lepidopterología. 12. 100329–100329. 11 indexed citations
3.
Lynch, Matthew, Naonori Kodate, Conor Hickey, & Aisling O’Leary. (2022). Bridging the gap between healthcare professions’ regulation and practice: the “lived experience” of community pharmacists in Ireland following regulatory change. Journal of Pharmaceutical Policy and Practice. 15(1). 74–74. 2 indexed citations
4.
Facey, Karen, Jaime Espín, E. Kent, et al.. (2021). Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel. PharmacoEconomics. 39(9). 1021–1044. 35 indexed citations
5.
Lynch, Matthew & Aisling O’Leary. (2020). COVID-19 related regulatory change for pharmacists – The case for its retention post the pandemic. Research in Social and Administrative Pharmacy. 17(1). 1913–1919. 15 indexed citations
6.
Thom, Howard, et al.. (2019). Incorporating single‐arm evidence into a network meta‐analysis using aggregate level matching: Assessing the impact. Statistics in Medicine. 38(14). 2505–2523. 16 indexed citations
7.
O’Leary, Aisling, et al.. (2019). Pharmacist-led pre-treatment assessment, management and outcomes in a Hepatitis C treatment patient cohort. International Journal of Clinical Pharmacy. 41(5). 1227–1238. 2 indexed citations
8.
9.
O’Leary, Aisling, et al.. (2018). The impact of individual patient data in a network meta‐analysis: An investigation into parameter estimation and model selection. Research Synthesis Methods. 9(3). 441–469. 12 indexed citations
10.
Cheallaigh, Clíona Ní, Aisling O’Leary, Eamon Keenan, et al.. (2017). Telementoring with project ECHO: a pilot study in Europe. BMJ Innovations. 3(3). 144–151. 35 indexed citations
11.
Strawbridge, Judith, James W. Barlow, Aisling O’Leary, et al.. (2017). Design and Evaluation of a New National Pharmacy Internship Program in Ireland. American Journal of Pharmaceutical Education. 83(4). 6678–6678. 6 indexed citations
12.
13.
Gray, Ewan, et al.. (2015). Estimation of The Relative Efficacy of Licensed Regimens for Genotype-1 Hcv Infection Using A Mixed Treatment Comparison. Value in Health. 18(7). A577–A577. 1 indexed citations
14.
Norris, Suzanne, Aisling O’Leary, Cathal Walsh, et al.. (2015). Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study. BMC Infectious Diseases. 15(1). 471–471. 18 indexed citations
15.
O’Leary, Aisling, Cara Usher, Mary A. Hall, et al.. (2015). Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland. BMC Research Notes. 8(1). 790–790. 29 indexed citations
16.
Nguyen, Linh T., Jonathan Dean, Michael J. Carr, et al.. (2014). Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations following Treatment in Chronic HCV Genotype-1-Infected Individuals. Antiviral Therapy. 20(8). 865–869. 19 indexed citations
17.
O’Leary, Aisling, et al.. (2014). Determinants of HIV Outpatient Service Utilization: A Systematic Review. AIDS and Behavior. 19(1). 104–119. 22 indexed citations
18.
Schmitz, Susanne, Aisling O’Leary, Cathal Walsh, et al.. (2012). The Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1. Clinical Infectious Diseases. 56(2). 228–235. 20 indexed citations
19.
Tilson, Lesley, Aisling O’Leary, Cara Usher, & Michael Barry. (2010). Pharmacoeconomic Evaluation in Ireland. PharmacoEconomics. 28(4). 307–322. 18 indexed citations
20.
Landers, Dónal, et al.. (1996). Dapsone induced methaemoglobinaemia. International Journal of STD & AIDS. 7(6). 445–446. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan Gardini Breakdown of academic impact, for papers by Kim Gilchrist Breakdown of academic impact, for papers by Lawrence Shaw Breakdown of academic impact, for papers by Naglaa Youssef Breakdown of academic impact, for papers by Aziz Rezapour Breakdown of academic impact, for papers by Stephen E. Van Rompaey Breakdown of academic impact, for papers by James Halloran Breakdown of academic impact, for papers by Tianhua He Breakdown of academic impact, for papers by Timothy Juday Breakdown of academic impact, for papers by M. M. Kitahata
Rankless by CCL
2026